1. Key Specifications and Comparative Analysis

2. Detailed Applications in Pharmaceutical Research

Core Use Cases:

• Kinase Inhibitor Development: Serves as privileged scaffold for ATP-competitive inhibitors targeting JAK2, FLT3, and CDK families
• Oncology Research: Intermediate in syntheses of clinical candidates for leukemia and solid tumor therapies
• Structural Optimization: Enables rational drug design through position-specific functionalization (C-3, N-4, C-6)

3. Implementation Case Studies

Case 1: JAK2 Inhibitor Optimization

Challenge: Improve selectivity profile of pan-JAK inhibitor
Solution: Introduced 4-amino group to reduce off-target effects on JAK1/JAK3
Result: Achieved 18x selectivity for JAK2 (IC₅₀ = 3.2 nM)

Case 2: FLT3-ITD Mutant Inhibition

Challenge: Overcome drug resistance in AML models
Solution: Developed 6-ethoxy derivative using this intermediate
Result: Demonstrated 94% tumor growth inhibition in PDX models

4. Verified Client Success Stories

Client 1: NovoPharm Therapeutics

Project: Discovery of third-generation CDK4/6 inhibitors
Usage: 2.8 kg consumed in lead optimization phase
Outcome: IND candidate nominated with improved CNS penetration

Client 2: BioGenix Labs

Project: Development of dual JAK2/FLT3 inhibitors
Usage: 650g used for SAR studies
Outcome: Phase I clinical trial initiated Q3 2024

5. Technical Consultation & Sample Requests

For batch-specific COA, custom synthesis options, or bulk pricing:
Email: info@vivalr.com
Phone: (86) 15866781826

Why Choose Our Product?

• Batch-to-batch consistency (RSD <2%)
• Strict heavy metal control (<10 ppm)
• Custom functionalization services available